Donald Trump Gilead Sciences Usa Canada covid-19 Coronavirus Donald Trump Gilead Sciences Usa Canada

U.S. buys up worldwide stock of remdesivir, drug seen as potential COVID-19 treatment

Reading now: 311
globalnews.ca

remdesivir, a drug that’s proven effective for severely ill patients of the novel coronavirus — leaving hardly any for Canada and the rest of the world.The Department of Health and Human Services (HHS) announced Monday it has secured more than 500,000 treatment courses of the drug from its sole manufacturer Gilead Sciences for American hospitals through September.

Each treatment course uses an average of over six vials of the drug. Coronavirus drug remdesivir to cost $2,340 per patient in the U.S.

According to a news release, the buyout represents 100 per cent of Gilead’s projected production for July, 90 per cent of August’s production, and 90 per cent of production through September.

Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA